These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 17950391

  • 1. Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis.
    Giunchetti RC, Reis AB, da Silveira-Lemos D, Martins-Filho OA, Corrêa-Oliveira R, Bethony J, Vale AM, da Silva Quetz J, Bueno LL, França-Silva JC, Nascimento E, Mayrink W, Fujiwara RT.
    Res Vet Sci; 2008 Aug; 85(1):106-12. PubMed ID: 17950391
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
    Araújo MS, de Andrade RA, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Vianna LR, Mayrink W, Reis AB, Malaquias LC, Mello MN, Martins-Filho OA.
    Vaccine; 2009 Feb 11; 27(7):1008-17. PubMed ID: 19110023
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A, Ojeda A, López-Fuertes L, Timón M, Altet L, Solano-Gallego L, Sánchez-Robert E, Francino O, Alberola J.
    Vaccine; 2007 Nov 14; 25(46):7962-71. PubMed ID: 17942199
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.
    Saldarriaga OA, Travi BL, Park W, Perez LE, Melby PC.
    Vaccine; 2006 Mar 10; 24(11):1928-40. PubMed ID: 16310897
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.
    Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, Mayrink W, Guerra LL, Andrade RA, Corrêa-Oliveira R, Martins-Filho OA.
    Vet Immunol Immunopathol; 2006 Aug 15; 112(3-4):102-16. PubMed ID: 16621021
    [Abstract] [Full Text] [Related]

  • 12. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
    Gradoni L, Foglia Manzillo V, Pagano A, Piantedosi D, De Luna R, Gramiccia M, Scalone A, Di Muccio T, Oliva G.
    Vaccine; 2005 Nov 01; 23(45):5245-51. PubMed ID: 16054272
    [Abstract] [Full Text] [Related]

  • 13. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro.
    Rodrigues CA, Batista LF, Teixeira MC, Pereira AM, Santos PO, de Sá Oliveira GG, de Freitas LA, Veras PS.
    Vet Parasitol; 2007 Feb 28; 143(3-4):197-205. PubMed ID: 17045743
    [Abstract] [Full Text] [Related]

  • 14. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
    Saraiva EM, de Figueiredo Barbosa A, Santos FN, Borja-Cabrera GP, Nico D, Souza LO, de Oliveira Mendes-Aguiar C, de Souza EP, Fampa P, Parra LE, Menz I, Dias JG, de Oliveira SM, Palatnik-de-Sousa CB.
    Vaccine; 2006 Mar 20; 24(13):2423-31. PubMed ID: 16386824
    [Abstract] [Full Text] [Related]

  • 15. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
    Daneshvar H, Molaei MM, Kamiabi H, Burchmore R, Hagan P, Stephen Phillips R.
    Parasite Immunol; 2010 Mar 20; 32(11-12):722-30. PubMed ID: 21039612
    [Abstract] [Full Text] [Related]

  • 16. Systemic and compartmentalized immune response in canine visceral leishmaniasis.
    Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Giunchetti RC, Carneiro CM, Mayrink W, Tafuri WL, Corrêa-Oliveira R.
    Vet Immunol Immunopathol; 2009 Mar 15; 128(1-3):87-95. PubMed ID: 19054576
    [Abstract] [Full Text] [Related]

  • 17. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
    de Andrade RA, Reis AB, Gontijo CM, Braga LB, Rocha RD, Araújo MS, Vianna LR, Martins-Filho OA.
    Vet Immunol Immunopathol; 2007 Mar 15; 116(1-2):85-97. PubMed ID: 17287029
    [Abstract] [Full Text] [Related]

  • 18. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.
    Nogueira FS, Moreira MA, Borja-Cabrera GP, Santos FN, Menz I, Parra LE, Xu Z, Chu HJ, Palatnik-de-Sousa CB, Luvizotto MC.
    Vaccine; 2005 Sep 23; 23(40):4805-10. PubMed ID: 16011864
    [Abstract] [Full Text] [Related]

  • 19. Antileishmanial antibody profile in dogs naturally infected with Leishmania chagasi.
    Almeida MA, Jesus EE, Sousa-Atta ML, Alves LC, Berne ME, Atta AM.
    Vet Immunol Immunopathol; 2005 Jun 15; 106(1-2):151-8. PubMed ID: 15911002
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection.
    Ramos I, Alonso A, Peris A, Marcen JM, Abengozar MA, Alcolea PJ, Castillo JA, Larraga V.
    Vaccine; 2009 Nov 12; 27(48):6695-703. PubMed ID: 19747996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.